SCIEX Launches the CESI 8000 Plus, a High Performance CESI-MS Platform that Delivers High Resolution and Ionization Efficiency
The next generation CESI-MS system extends capabilities for biopharmaceutical, proteomics and metabolomics researchers
The next generation CESI-MS system extends capabilities for biopharmaceutical, proteomics and metabolomics researchers
Which new product made the most difference to your laboratory in 2015?
Universal test designed for non-small cell lung cancer supports multiple drug development programs
Presents data on factors that affect the sensitivity of ADCC assays and discusses how to optimize methodology
Thermo Fisher Scientific showcases clinical research innovations at AMP 2015
Research is helping identify biomarkers of Alzheimer’s Disease
Comparative study of tumor biopsy v noninvasive blood-based analyses published
Booth 1415
KEYTRUDA is Merck's anti-PD-1 therapy for metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies
Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting
September 2nd-3rd, Telford, UK
Telford : Sept 2nd +3rd 2015
Range of antibodies to cardiac biomarkers conjugated to enzymes, fluorescent dyes and nanoparticles
The latest news from infectious disease industry specialists